China Health Industries Holdings, Inc. (CHHE) Receivables - Other (2016 - 2024)
China Health Industries Holdings (CHHE) has disclosed Receivables - Other for 14 consecutive years, with $3432.0 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Receivables - Other fell 88.14% year-over-year to $3432.0, compared with a TTM value of $3432.0 through Mar 2024, down 88.14%, and an annual FY2023 reading of $1921.0, down 93.95% over the prior year.
- Receivables - Other was $3432.0 for Q1 2024 at China Health Industries Holdings, down from $5617.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $38770.0 in Q1 2021 and bottomed at $1921.0 in Q2 2023.
- Average Receivables - Other over 5 years is $26143.6, with a median of $31778.0 recorded in 2022.
- The sharpest move saw Receivables - Other increased 28.26% in 2020, then tumbled 93.95% in 2023.
- Year by year, Receivables - Other stood at $34439.0 in 2020, then decreased by 4.51% to $32887.0 in 2021, then decreased by 8.26% to $30172.0 in 2022, then tumbled by 81.38% to $5617.0 in 2023, then plummeted by 38.9% to $3432.0 in 2024.
- Business Quant data shows Receivables - Other for CHHE at $3432.0 in Q1 2024, $5617.0 in Q4 2023, and $6172.0 in Q3 2023.